HCW Biologics (HCWB) Misses Q3 EPS by 202c

HCW Biologics (NASDAQ: HCWB) reported Q3 EPS of ($2.02). Revenue for the quarter came in at $15.6 million.

For earnings history and earnings-related data on HCW Biologics (HCWB) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters
• A. O. Smith CEO Stephen Shafer named chairman